Quality Control of Dietary Supplements - Chromatographic Approaches for CGMP Compliance
-
-
-
-
-
-LCGC's webinar, "Quality Control of Dietary Supplements: An Examination of Chromatographic Approaches Needed for cGMP Compliance, with Case Studies" is now available on-demand for you to view at your convenience along with a complimentary infographic.
-
-
-
TWO OPTIONS TO PARTICIPATE
- ON DEMAND WEBCAST - CLICK HERE TO REGISTER
- PRINTABLE INFOGRAPHIC -
-
-
-
The dietary supplement industry has grown to become a multibillion-dollar-a-year market. Concurrent with this growth, the FDA has implemented new current good manufacturing practices (cGMP) regulations (21 CFR part 111) that mandate appropriate quality control and process control testing for dietary supplements, from incoming materials to finished goods.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Understanding FDA Recommendations for N-Nitrosamine Impurity Levels
April 17th 2025We spoke with Josh Hoerner, general manager of Purisys, which specializes in a small volume custom synthesis and specialized controlled substance manufacturing, to gain his perspective on FDA’s recommendations for acceptable intake limits for N-nitrosamine impurities.
What Goes in a CDS IT Service Level Agreement?
Published: April 7th 2025 | Updated: April 7th 2025Protecting your network chromatography data system (CDS) data is critical and a service level agreement (SLA) with your IT provider is vital. What should be included? Are SLAs for in-house IT and SaaS (software as a service) similar?
